Empowering Global Health InnovationFounded in 2002, Trifermed is a leading strategic partner specializing in corporate strategy and business development across the Pharma, Biotech, Medtech, and Digital Health sectors. With 22 years of experience and over 200 strategic partnerships worldwide, we accelerate the development and value of healthcare companies, helping innovators scale and succeed in international markets.Our multidisciplinary team of experts transforms groundbreaking ideas into actionable, market-aligned strategies. From inbound and outbound processes in Life Sciences to fundraising and validating health innovations, we ensure that each collaboration is designed for long-term success.At Trifermed, our mission is clear: to lead in global health innovation and ensure that the benefits of our advancements reach everyone. We are committed to pushing the boundaries of what's possible in healthcare, driven by purpose and excellence.Key Services:- Corporate Strategy and Business Development in Health- Strategic Partnerships- Inbound and Outbound Processes in Life Sciences- Fundraising Support- Validating ideas in health- Supporting health innovators

Catalonia.Health (former CataloniaBio & HealthTech) represents companies in the biomedicine and health sectors in Catalonia. The organization works to:- Advocate for and promote the interests of businesses in the industry.- Increase the competitiveness and scale of companies to generate new products and services that improve people’s health.- Create value in the sector through innovation, entrepreneurship, and networking.- Position Catalonia as one of the leading health hubs in the world.Founded in 2006 by sector entrepreneurs, Catalonia.Health now includes over 200 companies and leading knowledge agents in research, development, and innovation.One of the key strengths of the organization is its cross-sector approach, enabling future synergies between start-ups and product-developing companies (biopharmaceuticals, medical technologies, and digital health), service providers (scientific and non-scientific), investors, research centers, and hospitals.

OBBIO Consulting is a business service provider specialized in corporate and business development in sectors with a strong R&D investment. The group participates in the design, development, and implementation of projects within high added value in sectors such as biotechnology, biomedicine, Agri-Food or Cosmetics.Responsible for the management of active accounts, identification and development of new biobusiness opportunities, Business modeling in Life Sciences, improvement of organization’s market position, building and management of R&D and early-stage businesses, partnerships between public and private entities, definition of long-term organizational strategic goals…- Business model design and validation- Promoting and Managing BioBusiness: From Bio to Business - Supporting early-stage life science and technology companies- Strategic project planning for biocompanies- Scouting- Innovation management - Open innovation- Fundraising- Scientific advising

Accelerating the value and growth of health organizations.Support to early-stage life science and biotech companies, integration into business and institutional environment, private and public fundraising, business modeling in Life Sciences, partnerships, etc…

Global Project Management in the field of Nanotechnology. Integration into business and institutional environment, strategic planning projects, national & international partnerships, etc.Development of an international collaborative project: “Nanoaerosols: Towards Inhaled Therapies of the Future”. (10 European partners, 14 MЄ requested)

The main focus of the research group was to understand how cells detect and respond to environmental changes. We focused the studies on the characterization of the osmo-stress signal transduction pathways, especially those controlled by MAP kinases of the Hog1/p38 family, also known as the stress-activated MAP kinases (SAPK). Using S. cerevisiae budding yeast, as a model organism, as well as higher eukaryotic cells, we studied the molecular mechanisms required to respond to changes in the extracellular environment and also which are the adaptive responses required for cell survival. Proper adaptation to stress involves the modulation of several basic aspects of cell biology, such as the control of cell cycle and regulation of gene expression. We also worked on the basic signaling properties of the HOG pathway and how to alter it, based on quantitative data collection and mathematical modeling, together with mutational analyses. In addition, we demonstrated that cellular communication using complex engineered networks can be implemented to perform in vivo cellular computation.Main activities/responsabilities: - planning, conception and development of scientific projects - writing of scientific articles - responsible for PhD students' formation.The UPF campus is located in the Barcelona Biomedical Research Park (PRBB), which conducts science of excellence in a wide diversity of fields, with a critical mass of 1,500 people, an accumulated R&D budget of approximately 90 M€ per year and cutting-edge scientific equipment.

Marie Curie Postdoctoral Researcher - European Community; Team leader: "Molecular determinants of sodium transport: role of NDRG2"

Water and solute transport processes in renal tubular epithelial cells: new insights.

“12(S)-Lipoxygenase Metabolism in essential hypertension”